You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股午評:恆指跌0.57%報24729點,航空股、博彩股上漲

港股上午盤三大指數下跌,恆指跌0.57%報24729點,國指跌0.52%報8775點,恆生科技指數跌1.43%報6187點。 南下資金半日淨流入6.39億港元,大市半日成交額為691億港元。

盤面上,大型科技股快手跌3%,百度、阿里巴巴,京東跌超2%,騰訊跌1%;受輝瑞新冠藥物療效顯著提振,香港本地股、旅遊股、航空股、餐飲股、博彩股、消費股集體上漲;受英美央行鴿派意向帶動金價,黃金股上漲,而鋼鐵股,鋼鐵股,石油股,煤炭,有色金屬板塊集體回暖。 波羅的海乾散運指數錄得2020年7月最大單週跌幅,海運股下挫,另外,醫藥外包,風電,抗疫概念股集體下跌。

旅遊股集體上漲,因輝瑞宣佈新冠口服藥療效顯著,經濟復甦概念股集體走強,其中,港股旅遊、酒店概念股表現強勢。同程藝龍漲超5%,雲頂香港、攜程集團漲超7%,香港中旅漲超4%。上週五,輝瑞宣佈其新冠口服藥物Paxlovid減少新冠肺炎非住院患者的住院或死亡率高達89%。這一數據媲美甚至好於新冠中和抗體,顯著優於默沙東的Molnupiravir。輝瑞計劃在本月尋求美國食品藥品監督管理局(FDA)批准該藥物,如果獲批,輝瑞可能在今年交付。

多重利好刺激 博彩股集體走強 金沙中國(1928.HK)漲7%,輝瑞新冠藥物療效顯著,以及港珠澳大橋或有機會成為與內地通關首批開放口岸之一的雙重利好刺激,港股博彩股今日集體走強。其中,金沙中國漲7%,澳博控股和銀河娛樂漲超5%,美高梅中國漲超4%,永利澳門漲超3%,新濠國際發展漲超5%。 輝瑞上週五宣佈其新冠口服藥物Paxlovid減少新冠肺炎非住院患者的住院或死亡率高達89%。 另外,香港特首林鄭月娥表示,香港要爭取與內地儘快通關,但不能要求內地大規模開放所有省市讓港人免檢疫進入,必須小規模、有序及逐步通關,預料通關初期只限廣東省地區,香港與深圳接壤的陸路口岸或港珠澳大橋可能是首批開放的口岸。

受英美央行鴿派意向帶動金價,港股黃金股走高,港股招金礦業,中國黃金國際漲4%,紫金礦業2%。 週一(11月8日)亞洲時段,現貨黃金窄幅震盪於1810上方,守住了上週的大部分漲幅,上週因為美聯儲、英國央行和歐洲央行都釋放了鴿派信號,幫助金價頂破了1800關口,並一度創近兩個月新高至1818.38美元/盎司,調查顯示,機構投資者和散户都傾向於看漲後市,金價本週有望進一步試探6月中旬以來的高點1834附近阻力。

海底撈(6862.HK)跳空漲超11% 宣佈年底前關店300家,海底撈(6862.HK)跳空上漲,盤初一度拉昇漲超11%報23.45港元,市值升至1280億港元。該股上週五盤中創調整新低價19.38港元。 公司上週五晚宣佈,決定在2021年12月31日前逐步關停300家左右客流量相對較低及經營業績不如預期的海底撈門店。據悉,減掉即將關停的約300家之後,海底撈門店總數仍在1300家以上。業內人士表示,海底撈此次採取的停業整合方式,是“進三退一”,意在及時止損,整編提質,符合企業螺旋上升的商業規律。從企業長遠發展來看,夯實基礎才能支撐起更廣闊的成長空間。

萬科企業高開,萬物雲將分拆赴港上市。萬科企業(2202.HK)高開4.58%,報17.8港元,總市值2069億港元。萬科企業公吿,於2021年11月5日,第十九屆董事會第十三次會議審議並批准了萬物雲境外上市相關議案。根據議案內容,公司擬分拆公司非全資附屬公司萬物雲於聯交所主板獨立上市。萬物雲成立於2001年2月20日,為公司非全資附屬子公司,主營業務為空間科技服務,主要包括物業管理、設施管理及智慧城市綜合服務。董事會認為,分拆萬物雲符合公司及股東的整體利益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account